Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breakthrough therapies
breakthrough therapies
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
FDA
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
Novartis
LDK378
serelaxin
daratumumab
Genmab
Tiny Catalyst soars after rare disease drug scores 'breakthrough' at FDA
Fierce Biotech
Tue, 08/27/13 - 11:01 am
Catalyst Pharmaceutical Partners
Firdapse
Biomarin
FDA
breakthrough therapies
Lambert-Eaton myasthenic syndrome
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
"Breakthrough Therapy" Status Could Hasten Novartis Drug Review
Motley Fool
Wed, 08/21/13 - 09:05 am
Novartis
breakthrough therapies
BYM338
sporadic inclusion body myositis
FDA
Breakthrough Status May Spur J&J Drug to Market Early
Bloomberg
Thu, 07/25/13 - 10:42 am
JNJ
breakthrough therapies
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
chronic lymphocytic leukemia
Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Forbes
Thu, 06/27/13 - 08:52 pm
breakthrough therapies
heart failure
Novatis
serelaxin
Glaxo grabs coveted breakthrough drug status for muscular dystrophy drug
Fierce Biotech
Thu, 06/27/13 - 11:56 am
breakthrough therapies
GSK
drisapersen
Duchenne Muscular Dystrophy
These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status
Yahoo/Street Authority
Fri, 06/14/13 - 12:21 pm
FDA
breakthrough therapies
LDK378
Novartis
palbociclib
Pfizer
lambrolizumab
Merck
Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
Seeking Alpha
Wed, 05/22/13 - 09:35 am
Merck
immunotherapy
lambrolizumab
breakthrough therapies
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Marketwatch
Mon, 05/6/13 - 11:34 am
FDA
breakthrough therapies
hepatitis C
AbbVie
Pages
« first
‹ previous
1
2
3